SRB Corp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,476
| Closed | -$601K | – | 103 |
|
|
2023
Q4 | $601K | Buy |
1,476
+162
| +12% | +$65.9K | 0.04% | 22 |
|
|
2023
Q3 | $457K | Hold |
1,314
| – | – | 0.03% | 61 |
|
|
2023
Q2 | $462K | Buy |
1,314
+79
| +6% | +$27.8K | 0.03% | 43 |
|
|
2023
Q1 | $389K | Sell |
1,235
-234
| -16% | -$73.7K | 0.02% | 19 |
|
|
2022
Q4 | $424K | Buy |
1,469
+47
| +3% | +$13.6K | 0.03% | 83 |
|
|
2022
Q3 | $412K | Buy |
+1,422
| New | +$412K | 0.03% | 29 |
|
|
2021
Q1 | – | Sell |
-3,474
| Closed | -$821K | – | 165 |
|
|
2020
Q4 | $821K | Buy |
+3,474
| New | +$821K | 0.06% | 56 |
|
|
2019
Q4 | – | Sell |
-2,443
| Closed | -$414K | – | 169 |
|
|
2019
Q3 | $414K | Sell |
2,443
-326
| -12% | -$55.2K | 0.04% | 156 |
|
|
2019
Q2 | $508K | Buy |
+2,769
| New | +$508K | 0.05% | 69 |
|